Market revenue in 2023 | USD 25.5 million |
Market revenue in 2030 | USD 64.9 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Epinephrine |
Fastest growing segment | Immunotherapies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antihistamines, Epinephrine, Immunotherapies, Other Drug Class |
Key market players worldwide | Nestle SA, Sanofi SA, DBV Technologies SA ADR, PureTech Health PLC, Regeneron Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd ADR, Protagonist Therapeutics Inc, Aravax, Alladapt Immunotherapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peanut allergy treatment market will help companies and investors design strategic landscapes.
Epinephrine was the largest segment with a revenue share of 48.63% in 2023. Horizon Databook has segmented the China peanut allergy treatment market based on antihistamines, epinephrine, immunotherapies, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
Peanut allergies appear to be a significant concern in Western countries but are notably less prevalent in other parts of the world, particularly in China. For instance, in Beijing, food allergies represent only a small percentage, ranging from 3.4% to 5.0% of all allergies, and these allergies are primarily associated with foods such as fish, shrimp, seaweed, and crab, rather than peanuts.
Interestingly, the Chinese-American community residing in the U.S. experiences a similar prevalence of peanut allergy as other American populations, highlighting potential environmental or lifestyle factors contributing to this difference.
Horizon Databook provides a detailed overview of country-level data and insights on the China peanut allergy treatment market , including forecasts for subscribers. This country databook contains high-level insights into China peanut allergy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account